Read + Share
Amedeo Smart
Independent Medical Education
Lallas A, Moscarella E, Kittler H, Longo C, et al. Real-world experience of off-label use of imiquimod 5% as an adjuvant therapy after surgery or as a monotherapy for lentigo maligna. Br J Dermatol 2021;185:675-677.PMID: 33894006
Email
LinkedIn
Facebook
Twitter
Privacy Policy